Consort Medical Plc, a global leader in the biotechnology, health care, and pharmaceutical industries, has brought together Aesica and Bespak to form a comprehensive drug and delivery device Contract Development and Manufacturing Organization (CDMO). With over 50 years of expertise in drug delivery device development and Aesica’s decade-long expansion into pharmaceutical CDMO, Consort Medical offers a single source solution for drug and delivery device development, manufacture, and formulation. This integrated approach aims to streamline and expedite the drug route to market for pharmaceutical customers. Boldly committed to investing in patient- and customer-driven innovation, Consort Medical is dedicated to pioneering new treatments, opening new markets, and creating fresh opportunities. Founded in 1946, Consort Medical is poised at the forefront of innovation, poised to make a lasting impact in the industry.
In summary, Consort Medical Plc leverages a rich heritage and extensive experience in drug delivery and pharmaceutical CDMO through the amalgamation of Aesica and Bespak. The company stands as a global leader in providing comprehensive solutions for drug and delivery device development, manufacture, and formulation. With a strong focus on innovation and customer-driven strategies, Consort Medical is poised to drive significant advancements and opportunities in the industry.
There is no investment information
No recent news or press coverage available for Consort Medical Plc.
We care about your data, and we'd love to use cookies make your experience better.